All Stories

  1. Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort Study
  2. One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease
  3. Monocyte Subset Predict Clinical Outcomes in Fibrotic Hypersensitivity Pneumonitis
  4. Psychometric Properties and Prognostic Value of the UCSD Shortness of Breath Questionnaire in Hypersensitivity Pneumonitis: A Prospective Cohort Study
  5. Rethinking the CT and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia
  6. Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
  7. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature
  8. Alternative assays for identifying the inciting antigen in hypersensitivity pneumonitis
  9. Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study
  10. Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
  11. Uncovering the Risk of Inhalational Exposures Across Interstitial Lung Diseases
  12. Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis
  13. Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report − Executive Summary
  14. Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
  15. Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report
  16. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs
  17. Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
  18. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases
  19. Soldiering on the Job When Ill: Productivity Costs in Connective Tissue Disease–associated Interstitial Lung Disease
  20. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis
  21. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
  22. Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
  23. Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management
  24. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
  25. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
  26. Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis-Related Mortality in the United States, 1999 to 2017
  27. Reply to Hall et al.: Hypersensitivity Pneumonitis Mortality by Industry and Occupation
  28. Increasing Hypersensitivity Pneumonitis–related Mortality in the United States from 1988 to 2016
  29. The Role of Computed Tomography Honeycombing in Profiling Disease Progression in Chronic Interstitial Lung Disease
  30. Changing trends in age-adjusted pulmonary fibrosis mortality in the USA: a joinpoint regression analysis
  31. United States trends in mortality rates for primary immunodeficiency diseases
  32. IPF Look-Alikes
  33. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
  34. Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement
  35. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey
  36. Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis
  37. An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
  38. Presence of Air Trapping and Mosaic Attenuation on Chest Computed Tomography Predicts Survival in Chronic Hypersensitivity Pneumonitis
  39. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
  40. Refining the Burden of Idiopathic Pulmonary Fibrosis: The Cocktail Party Effect
  41. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival
  42. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease
  43. Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome
  44. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
  45. Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
  46. Fibrotic hypersensitivity pneumonitis
  47. Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia
  48. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
  49. Nonasthmatic Eosinophilic Bronchitis
  50. Bronchiectasis
  51. Eosinophilic Lung Diseases
  52. Identifying an Inciting Antigen Is Associated With Improved Survival in Patients With Chronic Hypersensitivity Pneumonitis
  53. FEV1 over time in patients with connective tissue disease-related bronchiolitis
  54. Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
  55. Granulomatous Lymphocytic Interstitial Lung Disease
  56. Peeling away the layers of the volume-outcome effect and harvesting hidden connections*
  57. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
  58. Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease
  59. Rheumatoid Arthritis and Pneumoconiosis
  60. Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death
  61. Air hunger, unwelcome guests, clogged pipes and idiopathic inflammatory myositis: Can we do better?
  62. Interpretation of airway pressure waveforms
  63. Eosinophilic Lung Diseases
  64. Increased Risk of Pulmonary Embolism Among US Decedents With Sarcoidosis From 1988 to 2007
  65. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
  66. Derivation and Diagnostic Accuracy of the Surgical Lung Injury Prediction Model
  67. Sarcoidosis-related Mortality in the United States from 1988 to 2007
  68. Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
  69. Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality
  70. Long-Term Survival and Quality of Life After Transfusion-Associated Pulmonary Edema in Critically III Medical Patients
  71. Severity of Illness and Outcome in Patients With End-Stage Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation: Response
  72. Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
  73. Outcome of critically ill patients with influenza virus infection
  74. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
  75. Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
  76. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study
  77. Respiratory Monitoring
  78. Interpretation of airway pressure waveforms
  79. Ventilator Settings and Outcome of Respiratory Failure in Chronic Interstitial Lung Disease
  80. The Practice of Platelet Transfusion in the Intensive Care Unit
  81. The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit
  82. Nonfamilial hemophagocytic lymphohistiocytosis
  83. Post-thoracentesis trapped lung
  84. Acute pancreatitis due to hereditary angioedema
  85. Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study
  86. Intraoperative Tidal Volume as a Risk Factor for Respiratory Failure after Pneumonectomy
  87. A case of hydrocortisone desensitization in a patient with radiocontrast-induced anaphylactoid reaction and corticosteroid allergy
  88. Interpretation of airway pressure waveforms
  89. Sepsis during pregnancy
  90. Interpretation of airway pressure waveforms